Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Labeling Rule Delays Mount

Executive Summary

FDA plans another public hearing to solicit input and will reopen the docket, a sign that delaying tactics by opponents are working.

You may also be interested in...



Gottlieb Q&A: Sen. Murray Wants To Know About Generic Labeling Rule

US FDA Commissioner nominee offers master class in how to respond to congressional inquiries – and throws in some policy insight for good measure.

Gottlieb Q&A: Sen. Murray Wants To Know About Generic Labeling Rule

US FDA Commissioner nominee offers master class in how to respond to congressional inquiries – and throws in some policy insight for good measure.

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

But even though executive order that requires regulatory off sets may only have limited application to FDA, limited, experts warn that it still could prove extremely unwieldly to implement.

Related Content

Topics

UsernamePublicRestriction

Register

PS056640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel